US stocks surged on Monday as a coronavirus vaccine being developed by Moderna showed encouraging progress.
In a small number of healthy volunteers, Moderna's vaccine helped create immune responses that may help protect people from being infected with the novel coronavirus. The biotech is planning to start additional trials immediately and is aiming to be ready this fall for potential emergency use of its vaccine.
Investors have been closely watching for updates that can provide guidance around economic-reopening efforts, and were encouraged by Moderna's results.
No comments:
Post a Comment
Genuine commenting is warmly welcomed--Advertising is not welcome in the Comment Section and will be removed without further explanation.